RTS, S malaria vaccine and increased mortality in girls
Malaria was estimated to result in 214 million clinical cases and 438,000 deaths in 2015,
primarily in children under 5 years of age. In Africa, malaria causes approximately 10% of all …
primarily in children under 5 years of age. In Africa, malaria causes approximately 10% of all …
Promise of new malaria vaccines
PJ Hotez, M Matshaba - bmj, 2022 - bmj.com
Throughout the covid-19 pandemic, global health scientists and professionals worried not
only about this new and emerging viral infection but also about a potential diversion of …
only about this new and emerging viral infection but also about a potential diversion of …
[PDF][PDF] Malaria vaccine: WHO position paper–January 2016
S Agnandji - N Engl J Med, 2011 - cdn.who.int
BACKGROUND: An ongoing phase 3 study of the efficacy, safety, and immunogenicity of
candidate malaria vaccine RTS, S/AS01 is being conducted in seven African countries …
candidate malaria vaccine RTS, S/AS01 is being conducted in seven African countries …
First proven malaria vaccine rolled out in Africa--but doubts linger
A Maxmen - Nature, 2019 - go.gale.com
First proven malaria vaccine rolled out in Africa -- but doubts linger - Document - Gale
Academic OneFile Use this link to get back to this page. Copy Skip to Content Library Menu …
Academic OneFile Use this link to get back to this page. Copy Skip to Content Library Menu …
The RTS, S/AS01 malaria vaccine in children aged 5-17 months at first vaccination
P Vandoolaeghe, L Schuerman - The Pan African Medical Journal, 2018 - europepmc.org
Résumé Le vaccin antipaludique RTS, S/AS01 a reçu un avis scientifique favorable de
l'Agence Européenne des Médicaments (EMA) en Juillet 2015. L'Organisation Mondiale de …
l'Agence Européenne des Médicaments (EMA) en Juillet 2015. L'Organisation Mondiale de …
Feasibility, safety, and impact of the RTS, S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised …
Summary Background The RTS, S/AS01 E malaria vaccine (RTS, S) was introduced by
national immunisation programmes in Ghana, Kenya, and Malawi in 2019 in large-scale …
national immunisation programmes in Ghana, Kenya, and Malawi in 2019 in large-scale …
WHO's rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?
WHO’s rollout of malaria vaccine in Africa: can safety questions be answered after only 24
months? Page 1 WHO’s rollout of malaria vaccine in Africa: can safety questions be …
months? Page 1 WHO’s rollout of malaria vaccine in Africa: can safety questions be …
Safety profile of the RTS, S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
Y Guerra Mendoza, E Garric, A Leach… - Human vaccines & …, 2019 - Taylor & Francis
ABSTRACT A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-
Saharan Africa showed RTS, S/AS01 vaccine efficacy against malaria. We now present in …
Saharan Africa showed RTS, S/AS01 vaccine efficacy against malaria. We now present in …
[引用][C] Malaria vaccine cautiously recommended for use in Africa.
E Callaway, A Maxmen - Nature, 2015 - europepmc.org
Malaria vaccine cautiously recommended for use in Africa. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children
M Lievens, JJ Aponte, J Williamson, B Mmbando… - Malaria journal, 2011 - Springer
Background There has been much debate about the appropriate statistical methodology for
the evaluation of malaria field studies and the challenges in interpreting data arising from …
the evaluation of malaria field studies and the challenges in interpreting data arising from …